Physician profile
Mitchell Robert Rozman
NPI 1316564958
$4,203.83
in general payments reported to CMS, 2019-2025
27 companies · $1,874 in 2025
The $1,874 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $30.34 · 2021: $302 · 2022: $489 · 2023: $1,130 · 2024: $378 · 2025: $1,874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,171 · Education: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,171.02 |
| Education | $143.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $637.80 | 2025 | Assure Wcd |
| Inari Medical, INC. | $541.41 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $425.91 | 2022-2025 | Watchman Access System, Eluvia, Watchman Flx |
| Shockwave Medical, INC | $271.80 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $252.06 | 2025 | Azurion 7 M20, Encore |
| E.R. Squibb & Sons, L.L.C. | $218.34 | 2021-2023 | Eliquis, Camzyos |
| Edwards Lifesciences Corporation | $208.99 | 2023-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Penumbra, INC. | $154.98 | 2025 | Indigo System |
| Abbott Laboratories | $143.84 | 2024 | Ensite |
| Novo Nordisk INC | $120.72 | 2022 | |
| Cardiva Medical, INC. | $117.88 | 2023 | Cardiva Vascade 6/7f Vcs |
| Astrazeneca Pharmaceuticals Lp | $112.61 | 2021-2023 | Fasenra |
| Abbvie INC. | $96.90 | 2021-2023 | Dalvance |
| Cvrx, INC. | $91.78 | 2025 | Barostim Neo System |
| Amgen INC. | $85.82 | 2021-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $76.43 | 2024 | Arcalyst |
| Abiomed | $58.01 | 2024 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.61 | 2022-2023 | Jardiance |
| Medtronic, INC. | $50.04 | 2025 | Symplicity G3, Venaseal |
| Bayer Healthcare Pharmaceuticals INC. | $46.41 | 2022 | |
| Stryker Corporation | $33.80 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| La Jolla Pharmaceutical Company | $28.80 | 2021 | |
| Lantheus Medical Imaging, INC. | $20.96 | 2023 | Definity |
| Mallinckrodt Hospital Products INC. | $20.02 | 2021 | |
| Merck Sharp & Dohme LLC | $17.44 | 2024 | Verquvo |
| Alexion Pharmaceuticals, INC. | $16.82 | 2020 | |
| Nestle Healthcare Nutrition INC. | $15.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Rozman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.